Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.47 AUD | -2.65% | +0.41% | +93.15% |
02:10am | Telix Pharmaceuticals' Revenue Jumps 55% in Q2; Raises Guidance | MT |
01:14am | Telix Pharmaceuticals Limited Updates Earnings Guidance for the Fiscal Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+93.15% | 4.5B | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+44.87% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- TLX Stock
- News Telix Pharmaceuticals Limited
- Telix Pharmaceuticals' Revenue Jumps 55% in Q2; Raises Guidance